Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
Main Author: | Michel Burnier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537021002637 |
Similar Items
-
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
by: Moritz Mahling, et al.
Published: (2019-08-01) -
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.
by: David Cherney, et al.
Published: (2017-01-01) -
Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection
by: Adel E. Berbari
Published: (2020-12-01) -
Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.
by: Yanling Zhang, et al.
Published: (2016-01-01) -
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
by: Simes BC, et al.
Published: (2019-10-01)